drugset / Trial / NCT04591795

Sahastara Remedy Extract Capsule in Primary Osteoarthritis of Clinical Trial Phase II

NCT04591795

Phase 2 Unknown 80 enrolled Mr NARIN KAKATUM
RandomizedParallel-groupSingle-blindTreatment

Summary

To study efficacy and safety of Sahastara 95% ethanolic extract capsules compared to treatment Primary osteoarthritis for primary osteoarthritis, it was compared with diclofenac (Phase II).

Timeline

Start
2018-01-01
Primary completion
2020-10-13
Completion
2020-10-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 25 mg
Subject Sahastara remedy extract Unknown 100 mg

Indications